Background::
In medical imaging, Artificial Intelligence is described as the ability of a system to properly interpret and learn from external data, acquiring knowledge to achieve specific goals and tasks through flexible adaptation. The
number of possible applications of Artificial Intelligence is huge also in clinical medicine and in cardiovascular diseases.
Objective:
To describe for the first time in literature, the main results of articles about Artificial Intelligence potential for
clinical applications in molecular imaging techniques, and to describe its advancements in cardiovascular diseases assessed
with nuclear medicine imaging modalities.
Methods:
A comprehensive search strategy was used based on SCOPUS and PubMed databases. From all studies published in English, we selected the most relevant articles that evaluated the technological insights of AI in nuclear cardiology applications.
Results:
Artificial Intelligence may improve the patient care on many different fields, from the semi-automatization of the
medical work, through the technical aspect of image preparation, interpretation, the calculation of additional factors based
on data obtained during scanning, to the prognostic prediction and risk-group selection.
Conclusion:
Myocardial implementation of Artificial Intelligence algorithms in nuclear cardiology can improve and facilitate the diagnostic and predictive process, and global patient care. Building large databases containing clinical and image data is a first but essential step to create and train automated diagnostic/prognostic models able to help the clinicians to
make unbiased and faster decisions for precision healthcare.
Artificial intelligence in molecular imaging: at the crossroads of revolutions in medical diagnosis
